Avricore Health (TSX-V:AVCR, OTC:AVCRF) CEO Hector Bremner joined Steve Darling from Proactive to share some exciting news about the company's collaboration with Ascensia Diabetes Care, a global diabetes care company and a subsidiary of PHC Holdings Corporation. Avricore Health (TSX-V:AVCR, OTC:AVCRF) has entered into an agreement with Ascensia Diabetes Care to integrate their blood glucose monitoring systems, known as CONTOUR®NEXT GEN and CONTOUR®NEXT ONE, with Avricore's pharmacy-based point-of-care testing platform, HealthTab.
Bremner explained that this collaboration aims to provide better support to pharmacists in Canada to help them manage diabetes more effectively. By linking the daily blood glucose testing results and pattern history data collected via the CONTOUR®NEXT GEN or CONTOUR®NEXT ONE meter that the patient uses to the patient's HealthTab account, pharmacists will have access to valuable data insights for better patient care. The partnership also includes discussions on collaborative communications to ensure patients and pharmacists can take full advantage of the data insights offered by both technologies. The goal is to enhance patient engagement and improve diabetes management through a seamless integration of the blood glucose monitoring systems and HealthTab. Bremner further mentioned that Avricore Health and Ascensia Diabetes Care expect to conclude the technical work and launch the patient interface by the third quarter of this year. The companies will continue to work together to identify ways to effectively communicate and encourage patient engagement. Both parties are looking forward to updating on the progress as they continue their work in improving diabetes care and management in Canada.